Market Overview

Cancer Genetics (NASDAQ: CGIX)

4.00 -0.12 (-2.91%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:
-0.82
1.446M



Q1 2021
After-Hours
EPS:
REV:
-0.56
1.426M



Q4 2020
Pre-Market
EPS:
REV:
-0.14
1.9M



Q3 2020
Pre-Market
EPS:
REV:
-0.82
2.069M



Q2 2020
Pre-Market
EPS:
REV:
-0.01
1.525M

-0.82
1.446M

Q1 2020
After-Hours
EPS:
REV:
-1.06
1.8M

-0.56
1.426M

Q4 2019
Pre-Market
EPS:
REV:
-0.14
6.8M

-0.14
1.9M

Q3 2019
Pre-Market
EPS:
REV:
-0.31
535K

-0.82
2.069M

Q2 2019
Pre-Market
EPS:
REV:
-0.13
7.036M

-0.01
1.525M

Q1 2019
After-Hours
EPS:
REV:
-0.16
7.667M

10.77M
-0.90
6.839M

-36.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!